Genalin Moscoso-Stafford
Acute Care · Houston, TXNPI 1659046670
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,278, more than ten times the $178 reported in 2021. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $97.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- La Jolla Pharmaceutical Company$770
- Amgen$658
- AstraZeneca$644
- Mallinckrodt Hospital Products Inc.$496
- Axsome Therapeutics, Inc.$483
- plus $4K from 27 others
What the payments were for
- Food & beverage$8,636100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $1,199 |
| La Jolla Pharmaceutical Company | 7 | $770 |
| Amgen | 7 | $658 |
| AstraZeneca(2 entities) | 6 | $644 |
| Mallinckrodt Hospital Products Inc. | 4 | $496 |
| Axsome Therapeutics, Inc. | 4 | $483 |
| Merck | 5 | $474 |
| Actelion Pharmaceuticals US, Inc. | 3 | $374 |
| Gilead | 3 | $342 |
| Teva Pharmaceuticals USA, Inc. | 3 | $341 |
| BD | 3 | $314 |
| Nxstage Medical, Inc. | 4 | $266 |
| Neurocrine Biosciences, Inc. | 2 | $225 |
| Johnson & Johnson | 2 | $167 |
| Averitas Pharma Inc. | 1 | $134 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $128 |
| Sobi, Inc | 1 | $125 |
| Fresenius Kabi USA, LLC | 1 | $123 |
| Alcresta Therapeutics, Inc. | 1 | $122 |
| Philips North America LLC | 1 | $118 |
| Pacira Pharmaceuticals Incorporated | 1 | $116 |
| Sanofi | 1 | $113 |
| Edwards Lifesciences | 1 | $112 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Avita Medical Americas, LLC | 1 | $106 |
| Vantive US Healthcare LLC | 1 | $100 |
| Novo Nordisk | 1 | $98 |
| Vertex | 1 | $96 |
| Corcept Therapeutics | 1 | $83 |
| Biogen | 1 | $69 |
| SK Life Science, Inc. | 1 | $61 |
| Medtronic | 1 | $38 |
| Fresenius USA Marketing, Inc. | 1 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,636 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Other acute care in Houston
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Michelle JohnstonHouston$18K
- Amanda BergeronHouston$12K
- Nicole OnaHouston$12K
- Prashanth AnumandlaHouston$12K
- Ken ChanHouston$11K
- Brittney RichardHouston$11K
- Antonio Paolo AlmacenHouston$11K
- Laura WuesteHouston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.